InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
7
T+90 hit rate
25%
T+90 mean return
+1.8%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Kuhlmann Shirley R., Vice-Président Exécutif et Conseiller Juridique. Insider active across 2 companies, notably Collegium Pharmaceutical, INC. In total, 17 disclosures have been logged. Breakdown: 0 buy · 7 sells. Total volume traded: €2.6m. Activity tracked since 10 May 2021. The latest transaction was filed on 4 March 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations17 total
40,000 shares@ US$24.0321.0% of flowCommon StockSEC:0001062993-25-004776:0
40,965 shares0Common StockSEC:0001062993-25-002175:0
27,500 shares@ US$21.3413.1% of flowCommon StockSEC:0001062993-25-000761:0
16,848 shares@ US$38.1813.3% of flowCommon StockSEC:0001062993-24-016277:0
24,300 shares@ US$32.548416.6% of flowCommon StockSEC:0001062993-24-011979:0
43,400 shares0Common StockSEC:0001062993-24-003167:0
25,600 shares@ US$15.908.5% of flowCommon StockSEC:0001062993-23-021604:0
16,621 shares@ US$21.65447.6% of flowCommon StockSEC:0001062993-23-014095:0
48,125 shares0Common StockSEC:0001062993-23-003479:0
38,589 shares@ US$18.0716.0% of flowCommon StockSEC:0001062993-22-019618:0
300 shares@ US$20.010.1% of flowCommon StockSEC:0001062993-22-017994:0
734 shares@ US$18.990.0009% mcap7.5% of flowCommon StockSEC:0001062993-22-008131:0
56,700 shares0Common StockSEC:0001062993-22-004319:0
734 shares@ US$19.670.0008% mcap7.3% of flowCommon StockSEC:0001879789-21-000003:0
734 shares@ US$19.670.3% of flowCommon StockSEC:0001879789-21-000003
7,000 shares@ US$22.770.0089% mcap77.9% of flowCommon StockSEC:0001192482-21-000419:0
7,000 shares@ US$22.77100.0% of flowCommon StockSEC:0001192482-21-000419
17 of 17 declarations
About Kuhlmann Shirley R.
Shirley R. Kuhlmann is Executive Vice President and General Counsel at Collegium Pharmaceutical, Inc. She oversees the company's legal affairs and ensures regulatory compliance. Her expertise is essential for the company's legal strategy.
